A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy.
about
A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A Novel Strategy to Co-target ...... ugs for Breast Cancer Therapy.
@en
A Novel Strategy to Co-target ...... ugs for Breast Cancer Therapy.
@nl
type
label
A Novel Strategy to Co-target ...... ugs for Breast Cancer Therapy.
@en
A Novel Strategy to Co-target ...... ugs for Breast Cancer Therapy.
@nl
prefLabel
A Novel Strategy to Co-target ...... ugs for Breast Cancer Therapy.
@en
A Novel Strategy to Co-target ...... ugs for Breast Cancer Therapy.
@nl
P2093
P2860
P1433
P1476
A Novel Strategy to Co-target ...... rugs for Breast Cancer Therapy
@en
P2093
Gregory R J Thatcher
Jonna Frasor
Marton I Siklos
Svitlana D Brovkovych
P2860
P2888
P304
P356
10.1007/S12672-017-0294-5
P577
2017-04-10T00:00:00Z